When was Stratus Therapeutics founded?

Stratus Therapeutics was founded in 2021.

Where is Stratus Therapeutics located?

Stratus Therapeutics is headquartered in Cambridge, United States.

How many employees does Stratus Therapeutics have?

As of Jul 31, 2026, the latest employee count at Stratus Therapeutics is 12.

Where does Stratus Therapeutics rank among its competitors?

Stratus Therapeutics ranks 1226th amongst 2533 active competitors, of which 862 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was Sana Biotechnology, which secured $25M in Aug, 2026.

Who are the top competitors of Stratus Therapeutics?

Stratus Therapeutics' top competitors include Jazz Pharmaceuticals, Sana Biotechnology and Ideaya Biosciences. Among them, Sana Biotechnology secured the most recent funding round in August, 2026.

Stratus Therapeutics - 2026 Company Profile, Funding & Competitors

Stratus Therapeutics is a funded company based in Cambridge (United States), founded in 2021. It operates as an On-demand stem cell therapies for blood and immune system disorders. The company has 2533 active competitors, including 862 funded and 642 that have exited. Its top competitors include companies like Jazz Pharmaceuticals, Sana Biotechnology and Ideaya Biosciences.

Company Details

On-demand stem cell therapies for blood and immune system disorders. It develops on-demand hematopoietic stem cell therapies aimed at restoring the blood and immune system with off-the-shelf, immune-compatible grafts. Its lead program, ST-101, is designed to improve engraftment, speed immune recovery, and reduce graft-versus-host disease risk.

Website: stratustx.com
Email ID: *****@stratustx.com

Key Metrics

Founded Year

2021

Location

Cambridge, United States

Stage

Funding Raised

Investors

Orbimed

Ranked

1226^th among 2533 active competitors

Employee Count

12 as on Jul 31, 2026

Similar Companies

STAR Therapeutics & 138 more

View Stratus Therapeutics' full profile

Stratus Therapeutics is a funded company. Stratus Therapeutics has 1 institutional investor.

View details of Stratus Therapeutics's funding rounds and investors

Stratus Therapeutics' employee count trend

Stratus Therapeutics has 12 employees as of Jul 26. Here is Stratus Therapeutics's employee count trend over the years:

Employee count trend for Stratus Therapeutics

Uncover Stratus Therapeutics' growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Stratus Therapeutics include Jazz Pharmaceuticals, Sana Biotechnology and Ideaya Biosciences. Here is the list of Top 10 competitors of Stratus Therapeutics, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Jazz Pharmaceuticals 2003, Dublin (Ireland), Public	Developer of novel biopharmaceutical medicines for unmet medical needs	$265M	Versant Ventures, Prospect Venture Partners ... & 14 others	81/100
2nd	Sana Biotechnology 2018, Seattle (United States), Public	Developer of engineered cell therapies for treating various human diseases	$821M	Baillie Gifford, Google Ventures & 18 others	74/100
3rd	Ideaya Biosciences 2015, San Francisco (United States), Public	Developer of oncology-focused precision medicine using molecular diagnostics	$157M	BVF Partners, Boxer Capital & 15 others	73/100
4th	Sutro Biopharma 2003, United States, Public	Developer of antibody-based therapeutics for cancer therapy	$175M	Skyline Ventures, Alta Partners & 17 others	72/100
5th	Syndax 2005, Waltham (United States), Public	Developer of targeted therapies for the treatment of cancer	$198M	Fidelity Investments, Domain Associates & 19 others	72/100
6th	Immuneel 2018, Bengaluru (India), Series B	Developer of T-cell therapies for the treatment of cancer	$49.8M	F-Prime Capital, True North & 23 others	71/100
7th	C4 Therapeutics 2016, Cambridge (United States), Public	Developer of small molecule drugs for treating cancer	$223M	Cobro Ventures, Perceptive Advisors & 27 others	71/100
8th	Erasca 2018, San Diego (United States), Public	Developer of small molecule based therapeutics for cancer	$300M	Cormorant Asset Management, Arch Venture Partners ... & 13 others	71/100
9th	Elicio 2012, Cambridge (United States), Public	Developer of vaccines for treating cancer	$47.4M	Dreavent, Efung Capital & 5 others	71/100
10th	Celularity 2016, Warren (United States), Public	Developer of allogeneic cell therapies to treat multiple diseases	$290M	Celgene, Dreyfus Family Office & 8 others	71/100
1226th	Stratus Therapeutics 2021, Cambridge (United States), Funding Raised	On-demand stem cell therapies for blood and immune system disorders	-	Orbimed	20/100